SARCOIDOSIS GENETIC EPIDEMIOL: AFRICAN AMERICANS: GRANULOMAT & INFLAMMAT DISEASE
SARCOIDOSIS GENETIC EPIDEMIOL: AFRICAN AMERICANS: GRANULOMAT & INFLAMMAT DISEASE
批准号:
6206102
负责人:
MICHAEL C IANNUZZI
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2000-08-31
中文摘要
阻塞性睡眠呼吸暂停(OSA)的特征是大量的
睡眠时呼吸停止,
氧气饱和度下降,睡眠碎片,以及
打鼾和白天嗜睡。 据估计,7至
美国有1800万人患有轻度OSA,
1.8到400万人患有更严重的疾病。 OSA有
严重的心血管和神经心理后遗症。 的
诊断和治疗的估计费用从300万美元,
受影响最严重的是400亿美元,包括那些受影响较轻的国家。
OSA的形式。 在91个家庭的初始样本中,OSA的几率为1.3
在有一个受影响家庭成员的受试者中,
有三个受影响家庭成员的受试者,
对照组,与年龄、性别、种族和肥胖无关。 这是
提示阻塞性睡眠呼吸暂停综合征有遗传基础 隔离分析
表明呼吸暂停低通气指数具有家族性分布
作为两种分布的混合物,但不作为单一分布分离
孟德尔基因。 测量临床结果的其他方法正在
为了定义一种简单的继承模式,如果
可能 鉴于OSA的复杂性和
潜在的信息协变量,如解剖特征(肥胖
和颅面结构)和肺功能,分离
将对这些协变量进行分析。
英文摘要
Obstructive sleep apnea (OSA) is characterized by a high number of
episodes of cessation of breathing during sleep, and is associated
with oxygen desaturation, sleep fragmentation, and the symptoms of
disruptive snoring and daytime sleepiness. It is estimated that 7 to
18 million people in the U.S. suffer from a mild form of OSA and that
1.8 to 4 million are afflicted with a more severe form. OSA has
serious cardiovascular and neuro-psychological sequelae. The
estimated cost of diagnosis and treatment ranges from $3 million, for
the most severely affected to $40 billion including those with milder
forms of OSA. In an initial sample of 91 families, odds of OSA is 1.3
times greater in subjects with one affected family member, and 2.3
times greater in subjects with three affected family members, than in
controls, independent of age, sex, race, and obesity. This is
suggestive of an inherited basis for OSA. Segregation analyses have
indicated that the apopnea hypopnea index is distributed in families
as a mixture of two distributions but does not segregate as a single
Mendelian locus. Other ways of measuring clinical outcome are being
investigated with a view to defining a simple mode of inheritance, if
possible. Given the complex nature of OSA and the number of
potentially informative covariates such as anatomic features (obesity
and cranio-facial configuration) and pulmonary function, segregation
analyses will be conducted with these covariates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome Editing Therapy for Usher Syndrome Type 3
-
批准号:10759804
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2023
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
GENETIC EPIDEMIOLOGY OF SARCOIDOSIS IN AFRICAN AMERICANS
-
批准号:7723436
-
项目类别:
-
资助金额:$0.45万
-
财政年份:2008
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
GENETIC EPIDEMIOLOGY OF SARCOIDOSIS IN AFRICAN AMERICANS
-
批准号:7600974
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2007
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
GENETIC EPIDEMIOLOGY OF SARCOIDOSIS IN AFRICAN AMERICANS
-
批准号:7420622
-
项目类别:
-
资助金额:$0.74万
-
财政年份:2006
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
GENETIC EPIDEMIOLOGY OF SARCOIDOSIS IN AFRICAN AMERICANS
-
批准号:7181274
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2005
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
Gene Expression Profiling of the Kveim Siltzbach Test
-
批准号:6920009
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2004
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
GENETIC EPIDEMIOLOGY OF SARCOIDOSIS IN AFRICAN AMERICANS
-
批准号:6977676
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2004
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
ADMIXTURE LINKAGE DISEQUILIBIRUM IN AFRICAN-AMERICANS
-
批准号:6977694
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2004
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
Gene Expression Profiling of the Kveim Siltzbach Test
-
批准号:6816495
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2004
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
CORE--CLINICAL
-
批准号:6631286
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2002
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
SARCOIDOSIS GENETIC EPIDEMIOL: AFRICAN AMERICANS: GRANULOMAT & INFLAMMAT DISEASE
-
批准号:6491961
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2001
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
CORE--CLINICAL
-
批准号:6455808
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2001
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
CORE--CLINICAL
-
批准号:6323387
-
项目类别:
-
资助金额:$55.12万
-
财政年份:2000
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
SARCOIDOSIS GENETIC EPIDEMIOL: AFRICAN AMERICANS: GRANULOMAT & INFLAMMAT DISEASE
-
批准号:6348132
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2000
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
SARCOIDOSIS GENETIC LINKAGE CONSORTIUM
-
批准号:6184469
-
项目类别:
-
资助金额:$199.44万
-
财政年份:1999
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
CORE--CLINICAL
-
批准号:6128153
-
项目类别:
-
资助金额:$55.12万
-
财政年份:1999
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
SARCOIDOSIS GENETIC LINKAGE CONSORTIUM
-
批准号:6389911
-
项目类别:
-
资助金额:$203.05万
-
财政年份:1999
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
CORE--CLINICAL
-
批准号:6217872
-
项目类别:
-
资助金额:$55.12万
-
财政年份:1999
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
SARCOIDOSIS GENETIC LINKAGE CONSORTIUM
-
批准号:6147242
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1999
-
负责人:MICHAEL C IANNUZZI
-
依托单位:
SARCOIDOSIS GENETIC LINKAGE CONSORTIUM
-
批准号:6638493
-
项目类别:
-
资助金额:$83.31万
-
财政年份:1999
-
负责人:MICHAEL C IANNUZZI
-
依托单位: